THC Global Group Limited has been granted a Manufacture Permit from the Australian Office of Drug Control for the Company’s Southport Manufacturing Facility.
"The Manufacture Permit allows the Company to now accept medicinal cannabis plant material from any Australian licenced and permitted cultivator, including from the Company’s own cultivation facilities, and to immediately commence production of Australian medicinal cannabis medicines," the team with the company explains.
"With the granting of the Manufacture Permit for the Southport Facility, THC Global now has one of the largest extraction capacities for medicinal cannabis in Australia, with the capability to support a minimum of 250,000 Australian patients in addition to having excess capacity for the global export market."
"THC Global will be able to produce both packaged and bulk medicinal cannabis from the Southport Facility. The Company expects product validation to commence shortly, and be completed in December, supporting a commercial launch in early 2020."
Chief Executive Officer, Ken Charteris, commented: “This is a major milestone for THC Global, and for the Australian medicinal cannabis industry as a whole, with THC Global now able to operate the largest pharmaceutical bio-floral extraction facility in the Southern Hemisphere. Our scale and technology will enable us to offer patients a higher quality, more consistent cannabis medicine at a significantly lower cost than the current imported products available to Australian patients”.
"The receipt of the Manufacture Permit for the Southport Facility confirms that the Company has now met all the regulatory steps set by the Australian Office of Drug Control prior to commencing the processing of medicinal cannabis at the Southport Facility," they further explain. "In addition to the Company’s earlier receipt of Schedule 4 pharmacy medicines and Schedule 8 controlled substances manufacture and wholesale licences, THC Global is now fully licenced and permitted for medicinal cannabis production at the Southport Facility. These approvals include use of the Company’s on-site product testing laboratory which will significantly reduce ongoing research and development costs."
For more information:
THC Global Group
Level 2, 131 Macquarie St
Sydney NSW 2000
+61 (0)2 9251 7177
thc.global